Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV-2 spike protein.
作者信息
Yamamoto Fumiichiro, Cid Emili, Yamamoto Miyako, Muñiz-Diaz Eduardo
机构信息
Laboratory of Immunohematology and Glycobiology, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
Department of Immunohematology, Banc de Sang i Teixits - BST, Barcelona, Spain.
出版信息
Vox Sang. 2022 Sep;117(9):1126-1127. doi: 10.1111/vox.13341. Epub 2022 Aug 2.
Abstract
摘要
相似文献
1
Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV-2 spike protein.ABO血型多态性对针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白的新冠病毒mRNA疫苗抗体反应的影响不大。
Vox Sang. 2022 Sep;117(9):1126-1127. doi: 10.1111/vox.13341. Epub 2022 Aug 2.
2
Response to 'Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV-2 spike protein'.对《ABO血型多态性对COVID-19 mRNA疫苗针对SARS-CoV-2刺突蛋白抗体反应的影响不太可能》的回应
Vox Sang. 2022 Sep;117(9):1128. doi: 10.1111/vox.13340. Epub 2022 Aug 2.
3
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
4
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.辉瑞-BioNTech 新冠疫苗接种 6 个月后针对 SARS-CoV-2 关注变异株的抗体反应
Microbiol Spectr. 2022 Apr 27;10(2):e0225221. doi: 10.1128/spectrum.02252-21. Epub 2022 Mar 9.
5
A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity.含有 D614G 和 BA.1 刺突三聚体蛋白的二价疫苗或 BA.1 刺突三聚体蛋白加强针可产生广泛的中和免疫。
J Med Virol. 2022 Sep;94(9):4287-4293. doi: 10.1002/jmv.27885. Epub 2022 Jun 2.
6
Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates.SARS-CoV-2 mRNA 和重组蛋白候选疫苗引起的免疫反应比较。
Front Immunol. 2022 May 19;13:906457. doi: 10.3389/fimmu.2022.906457. eCollection 2022.
7
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.感染或接种疫苗后针对 SARS-CoV-2 奥密克戎变异株的抗体亲合力和中和反应。
J Immunol Res. 2022 Aug 31;2022:4813199. doi: 10.1155/2022/4813199. eCollection 2022.
8
9
Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination.感染和接种后对 SARS-CoV-2 的异源中和活性。
Front Immunol. 2022 May 30;13:888794. doi: 10.3389/fimmu.2022.888794. eCollection 2022.
10
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees.奥密克戎 BA.1 和 BA.2 中和抗体在 COVID-19 mRNA 疫苗接种者中的结构分析。
Nat Commun. 2022 Jun 13;13(1):3375. doi: 10.1038/s41467-022-31115-8.
引用本文的文献
1
Response to 'Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV-2 spike protein'.对《ABO血型多态性对COVID-19 mRNA疫苗针对SARS-CoV-2刺突蛋白抗体反应的影响不太可能》的回应
Vox Sang. 2022 Sep;117(9):1128. doi: 10.1111/vox.13340. Epub 2022 Aug 2.
本文引用的文献
1
Does ABO blood group influence antibody response to SARS-CoV-2 vaccination?ABO血型会影响对SARS-CoV-2疫苗接种的抗体反应吗？
Vox Sang. 2022 May;117(5):754-755. doi: 10.1111/vox.13241. Epub 2021 Dec 28.
2
ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data.ABO 血型与 COVID-19：虚假的、传闻的，还是真正重要的关系？对现有数据的合理回顾。
Viruses. 2021 Jan 22;13(2):160. doi: 10.3390/v13020160.
3
Blood group ABO polymorphism inhibits SARS-CoV-2 infection and affects COVID-19 progression.ABO血型多态性可抑制新型冠状病毒感染并影响新冠肺炎病情进展。
Vox Sang. 2021 Jan;116(1):15-17. doi: 10.1111/vox.13004. Epub 2020 Sep 23.
Zotero 插件